Stephen J. Headey

Stephen J. Headey

Auto-generated profile, based on publicly available information

Stephen J. Headey

School of Science, RMIT University, Melbourne, VIC, 3000, Australia.

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
LBLeon Bach
Leon Bach
SHS Headey
S Headey
Raymond NortonRaymond Norton
Raymond Norton

19 May 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
ARAmy L. Robertson
Amy L. Robertson
SHStephen J. Headey
Stephen J. Headey
HSHelen M. Saunders
Helen M. Saunders
HEHeath Ecroyd
Heath Ecroyd
MSMartin J. Scanlon
Martin J. Scanlon
SBStephen P. Bottomley
Stephen P. Bottomley
Small heat-shock proteins (sHsps) are molecular chaperones that play an important protective role against cellular protein misfolding by interacting with partially unfolded proteins on their off-folding pathway, preventing their aggregation. Polyglutamine (polyQ) repeat expansion leads to the formation of fibrillar protein aggregates and neuronal cell death in nine diseases, including Huntington disease and the spinocerebellar ataxias (SCAs). There is evidence that sHsps have a role in suppression of polyQ-induced neurodegeneration; for example, the sHsp alphaB-crystallin (αB-c) has been identified as a suppressor of SCA3 toxicity in a Drosophila model. However, the molecular mechanism for this suppression is unknown. In this study we tested the ability of αB-c to suppress the aggregation of a polyQ protein. We found that αB-c does not inhibit the formation of SDS-insoluble polyQ fibrils. We further tested the effect of αB-c on the aggregation of ataxin-3, a polyQ protein that aggregates via a two-stage aggregation mechanism. The first stage involves association of the N-terminal Josephin domain followed by polyQ-mediated interactions and the formation of SDS-resistant mature fibrils. Our data show that αB-c potently inhibits the first stage of ataxin-3 aggregation; however, the second polyQ-dependent stage can still proceed. By using NMR spectroscopy, we have determined that αB-c interacts with an extensive region on the surface of the Josephin domain. These data provide an example of a domain/region flanking an amyloidogenic sequence that has a critical role in modulating aggregation of a polypeptide and plays a role in the interaction with molecular chaperones to prevent this aggregation.

1 February 2013 in SLAS Discovery
Verified
Journal Article
Open access
JWJerome Wielens
Jerome Wielens
SHStephen J. Headey
Stephen J. Headey
DRDavid I. Rhodes
David I. Rhodes
RMRoger Mulder
Roger Mulder
ODOlan Dolezal
Olan Dolezal
MSMartin J. Scanlon
Martin J. Scanlon
Fragment screening is becoming widely accepted as a technique to identify hit compounds for the development of novel lead compounds. In neighboring laboratories, we have recently, and independently, performed a fragment screening campaign on the HIV-1 integrase core domain (IN) using similar commercially purchased fragment libraries. The two campaigns used different screening methods for the preliminary identification of fragment hits; one used saturation transfer difference nuclear magnetic resonance spectroscopy (STD-NMR), and the other used surface plasmon resonance (SPR) spectroscopy. Both initial screens were followed by X-ray crystallography. Using the STD-NMR/X-ray approach, 15 IN/fragment complexes were identified, whereas the SPR/X-ray approach found 6 complexes. In this article, we compare the approaches that were taken by each group and the results obtained, and we look at what factors could potentially influence the final results. We find that despite using different approaches with little overlap of initial hits, both approaches identified binding sites on IN that provided a basis for fragment-based lead discovery and further lead development. Comparison of hits identified in the two studies highlights a key role for both the conditions under which fragment binding is measured and the criteria selected to classify hits.

13 May 2021 in Blood
Verified
Journal Article
Closed access
PDF file
SRSuk See De Ravin
Suk See De Ravin
JBJulie Brault
Julie Brault
RMRonald J. Meis
Ronald J. Meis
SLSiyuan Liu
Siyuan Liu
LLLinhong Li
Linhong Li
HMHarry L. Malech
Harry L. Malech
Lentivector gene therapy for X-linked chronic granulomatous disease (X-CGD) has proven to be a viable approach, but random vector integration and subnormal protein production from exogenous promoters in transduced cells remain concerning for long-term safety and efficacy. A previous genome editing-based approach using SpCas9 and an oligodeoxynucleotide donor to repair genetic mutations demonstrated the capability to restore physiological protein expression, but lacked sufficient efficiency in quiescent CD34+ hematopoietic cells for clinical translation. Here, we show transient inhibition of p53-binding protein 1 (53BP1) significantly increased (2.3-fold) long-term homology directed repair (HDR) to achieve highly efficient (80% gp91phox+ cells compared to healthy donor control) long-term correction of X-CGD CD34+ cells.

14 August 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Damià GarrigaDamià Garriga
Damià Garriga
SHStephen Headey
Stephen Headey
CACathy Accurso
Cathy Accurso
MGMenachem Gunzburg
Menachem Gunzburg
MSMartin Scanlon
Martin Scanlon
FCFasseli Coulibaly
Fasseli Coulibaly
Significance: Most antibiotics do not interfere with viral infections. Rifampicin is a notable exception, as it inhibits several poxviruses, including the causative agent of smallpox. However, the inhibition of viral assembly is unrelated to the antibacterial activity of rifampicin against microbial RNA polymerases. Here, we reveal how the antibiotic prevents the recruitment of an essential scaffolding protein to nascent viral membranes. Based on these results, we provide a structural model of membrane assembly that is distinct from budding through cellular membranes and is most likely conserved in many large DNA viruses. Together, the mechanism of membrane assembly and structural models provide avenues to develop broad spectrum inhibitors against human and animal poxviruses.

30 December 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
LALuke A. Adams
Luke A. Adams
PSPooja Sharma
Pooja Sharma
BMBiswaranjan Mohanty
Biswaranjan Mohanty
OIOlga V. Ilyichova
Olga V. Ilyichova
MMMark D. Mulcair
Mark D. Mulcair
MSMartin J. Scanlon
Martin J. Scanlon